IN BRIEF: 4basebio works with eTheRNA on research collaboration

4basebio PLC - Cambridge, England-based biotechnology - Announces a research collaboration ...

Alliance News 19 January, 2022 | 9:26AM
Email Form Facebook Twitter LinkedIn RSS

4basebio PLC - Cambridge, England-based biotechnology - Announces a research collaboration between its subsidiary 4basebio Discovery Ltd and the Niel, Belgium-based peer eTheRNA immunotherapies NV. Says the companies will work on the use of 4basebio's synthetic osDNA technology as a template for eTheRNA's in vitro mRNA production. A successful outcome of this research collaboration could pave the way for the use of a new and cost-effective DNA template for in vitro transcription mRNA synthesis, 4basebio says.

Current stock price: 600.00 pence

12-month change: up 78%

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
4basebio PLC Ordinary Shares 1,035.00 GBX 0.00 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures